These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 28636940)
41. Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System. Hallett ST; Pastok MW; Morgan RML; Wittner A; Blundell KLIM; Felletar I; Wedge SR; Prodromou C; Noble MEM; Pearl LH; Endicott JA Cell Rep; 2017 Oct; 21(5):1386-1398. PubMed ID: 29091774 [TBL] [Abstract][Full Text] [Related]
42. Production and purification of human Hsp90β in Escherichia coli. Radli M; Veprintsev DB; Rüdiger SGD PLoS One; 2017; 12(6):e0180047. PubMed ID: 28651008 [TBL] [Abstract][Full Text] [Related]
43. Escorting Client Proteins to the Hsp90 Molecular Chaperone. Eickhoff P; Costa A Structure; 2017 Jul; 25(7):964-965. PubMed ID: 28683276 [TBL] [Abstract][Full Text] [Related]
44. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus. Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869 [TBL] [Abstract][Full Text] [Related]
45. Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients. Woodford MR; Sager RA; Marris E; Dunn DM; Blanden AR; Murphy RL; Rensing N; Shapiro O; Panaretou B; Prodromou C; Loh SN; Gutmann DH; Bourboulia D; Bratslavsky G; Wong M; Mollapour M EMBO J; 2017 Dec; 36(24):3650-3665. PubMed ID: 29127155 [TBL] [Abstract][Full Text] [Related]
46. Symmetry broken and rebroken during the ATP hydrolysis cycle of the mitochondrial Hsp90 TRAP1. Elnatan D; Betegon M; Liu Y; Ramelot T; Kennedy MA; Agard DA Elife; 2017 Jul; 6():. PubMed ID: 28742020 [TBL] [Abstract][Full Text] [Related]
47. Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3. Schoebel S; Mi W; Stein A; Ovchinnikov S; Pavlovicz R; DiMaio F; Baker D; Chambers MG; Su H; Li D; Rapoport TA; Liao M Nature; 2017 Aug; 548(7667):352-355. PubMed ID: 28682307 [TBL] [Abstract][Full Text] [Related]
48. Wnt-Dependent Inactivation of the Groucho/TLE Co-repressor by the HECT E3 Ubiquitin Ligase Hyd/UBR5. Flack JE; Mieszczanek J; Novcic N; Bienz M Mol Cell; 2017 Jul; 67(2):181-193.e5. PubMed ID: 28689657 [TBL] [Abstract][Full Text] [Related]
49. Repair or destruction-an intimate liaison between ubiquitin ligases and molecular chaperones in proteostasis. Kevei É; Pokrzywa W; Hoppe T FEBS Lett; 2017 Sep; 591(17):2616-2635. PubMed ID: 28699655 [TBL] [Abstract][Full Text] [Related]
50. Protein homeostasis of a metastable subproteome associated with Alzheimer's disease. Kundra R; Ciryam P; Morimoto RI; Dobson CM; Vendruscolo M Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5703-E5711. PubMed ID: 28652376 [TBL] [Abstract][Full Text] [Related]
51. An HSP90 co-chaperone controls circadian proteostasis. Kim J; Somers DE Cell Cycle; 2017 Aug; 16(16):1483-1484. PubMed ID: 28722533 [No Abstract] [Full Text] [Related]
52. Differential effects of heat shock protein 90 and serine 1179 phosphorylation on endothelial nitric oxide synthase activity and on its cofactors. Chen Y; Jiang B; Zhuang Y; Peng H; Chen W PLoS One; 2017; 12(6):e0179978. PubMed ID: 28654706 [TBL] [Abstract][Full Text] [Related]
53. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation. Cho JJ; Xu Z; Parthasarathy U; Drashansky TT; Helm EY; Zuniga AN; Lorentsen KJ; Mansouri S; Cho JY; Edelmann MJ; Duong DM; Gehring T; Seeholzer T; Krappmann D; Uddin MN; Califano D; Wang RL; Jin L; Li H; Lv D; Zhou D; Zhou L; Avram D Nat Commun; 2019 Feb; 10(1):701. PubMed ID: 30741923 [TBL] [Abstract][Full Text] [Related]
54. The role of E3 ubiquitin ligase HECTD3 in cancer and beyond. Jiang Q; Li F; Cheng Z; Kong Y; Chen C Cell Mol Life Sci; 2020 Apr; 77(8):1483-1495. PubMed ID: 31637449 [TBL] [Abstract][Full Text] [Related]
55. The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice. Rangrez AY; Borlepawar A; Schmiedel N; Deshpande A; Remes A; Kumari M; Bernt A; Christen L; Helbig A; Jungmann A; Sossalla S; Tholey A; Müller OJ; Frank D; Frey N Commun Biol; 2020 Oct; 3(1):562. PubMed ID: 33037313 [TBL] [Abstract][Full Text] [Related]
56. HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection. Li F; Li Y; Liang H; Xu T; Kong Y; Huang M; Xiao J; Chen X; Xia H; Wu Y; Zhou Z; Guo X; Hu C; Yang C; Cheng X; Chen C; Qi X J Clin Invest; 2018 Aug; 128(9):4148-4162. PubMed ID: 29920190 [TBL] [Abstract][Full Text] [Related]
57. CUL-6/cullin ubiquitin ligase-mediated degradation of HSP-90 by intestinal lysosomes promotes thermotolerance. Bardan Sarmiento M; Gang SS; van Oosten-Hawle P; Troemel ER Cell Rep; 2024 Jun; 43(6):114279. PubMed ID: 38795346 [TBL] [Abstract][Full Text] [Related]
58. HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway. Zhang G; Tan R; Wan S; Yang R; Hu X; Zhao E; Ding X; Zhang J; Li B; Liang P; Cui H Br J Cancer; 2022 Nov; 127(11):1925-1938. PubMed ID: 36088509 [TBL] [Abstract][Full Text] [Related]
59. Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations. Wang F; Zhang H; Wang H; Qiu T; He B; Yang Q Med Oncol; 2022 Sep; 39(12):180. PubMed ID: 36071247 [TBL] [Abstract][Full Text] [Related]